Lexaria Bioscience Corp (LEXX)

Nov 15, 2024

LEXXWLexaria Bioscience Corp. Warrant Latest Stock News & Market Updates - StockTitan

Nov 15, 2024

Nov 15, 2024

Invenomic Capital Management LP Adjusts Stake in Lexaria Bioscie - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Lexaria commences unique drug distribution study - Investing.com

Nov 14, 2024

Nov 14, 2024

Lexaria Launches Groundbreaking Semaglutide Study vs. Rybelsus Formulation | LEXX Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

LEXXLexaria Bioscience Corp. Latest Stock News & Market Updates - StockTitan

Nov 13, 2024

Nov 13, 2024

Lexaria's DehydraTECH Diabetes Study Advances: FDA-Track Phase 1b Trial Gets Key Approval | LEXX Stock News - StockTitan

Nov 13, 2024

Nov 12, 2024

Lexaria Bioscience Corp. (LEXX) Quarterly 10-Q Report - Quartzy

Nov 12, 2024

Nov 07, 2024

Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Lexaria Positions DehydraTECH Platform in Booming $471B GLP-1 Drug Market | LEXX Stock News - StockTitan

Nov 07, 2024

Oct 25, 2024

Lexaria reports promising blood sugar control in animal study - Investing.com India

Oct 25, 2024

Oct 24, 2024

Lexaria reports promising blood sugar control in animal study By Investing.com - Investing.com Australia

Oct 24, 2024

Oct 24, 2024

Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study - StockTitan

Oct 24, 2024

Oct 23, 2024

Lexaria reports advances in weight loss drug study - Investing.com India

Oct 23, 2024

Oct 22, 2024

Lexaria reports advances in weight loss drug study By Investing.com - Investing.com UK

Oct 22, 2024

Oct 22, 2024

Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study - StockTitan

Oct 22, 2024

Oct 21, 2024

Lexaria Bioscience : Corporate Presentation - Marketscreener.com

Oct 21, 2024

Oct 18, 2024

Lexaria Bioscience Corp. sets date for combined annual and special meeting - Investing.com India

Oct 18, 2024

Oct 17, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 17, 2024

Oct 16, 2024

Lexaria Bioscience : Registered Direct Offering Form 8 K - Marketscreener.com

Oct 16, 2024

Oct 16, 2024

Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

Oct 16, 2024

Oct 16, 2024

Companies Like Lexaria Bioscience (NASDAQ:LEXX) Are In A Position To Invest In Growth - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Lexaria Bioscience announces $5M securities offering - MSN

Oct 15, 2024

Oct 15, 2024

Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

Oct 15, 2024

Oct 10, 2024

Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes - MSN

Oct 10, 2024

Oct 09, 2024

Lexaria starts pilot study for oral diabetes treatment By Investing.com - Investing.com South Africa

Oct 09, 2024

Oct 09, 2024

Lexaria starts pilot study for oral diabetes treatment - Investing.com

Oct 09, 2024

Oct 09, 2024

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing - StockTitan

Oct 09, 2024

Oct 09, 2024

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing | LEXX Stock News - StockTitan

Oct 09, 2024

Oct 08, 2024

Lexaria Foresees Lead in Booming GLP-1 Market - TipRanks

Oct 08, 2024

Oct 08, 2024

Lexaria Updates Current GLP-1 Market - Yahoo Finance

Oct 08, 2024

Oct 07, 2024

Why Lexaria Bioscience (LEXX) Shares Are Moving - MSN

Oct 07, 2024

Oct 02, 2024

Lexaria Bioscience appoints new CFO Michael Shankman - Investing.com

Oct 02, 2024

Oct 02, 2024

Lexaria Bioscience appoints new CFO Michael Shankman By Investing.com - Investing.com Canada

Oct 02, 2024

Oct 01, 2024

Lexaria Bioscience appoints new CFO amid growth plans By Investing.com - Investing.com Australia

Oct 01, 2024

Oct 01, 2024

Lexaria Bioscience appoints new CFO amid growth plans - Investing.com

Oct 01, 2024

Oct 01, 2024

Lexaria Bioscience Welcomes New CFO Amid Growth - TipRanks

Oct 01, 2024

Oct 01, 2024

Lexaria Bioscience Corp. Appoints Michael Shankman as Chief Financial Officer - Marketscreener.com

Oct 01, 2024

Sep 27, 2024

Lexaria Advances Oral Diabetes Treatment Study - TipRanks

Sep 27, 2024

Sep 27, 2024

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3 - StockTitan

Sep 27, 2024

Sep 25, 2024

Stocks of Lexicon Pharmaceuticals Inc (LXRX) are poised to climb above their peers - SETE News

Sep 25, 2024

Sep 25, 2024

XTX Topco Ltd Raises Stock Holdings in Lantronix, Inc. (NASDAQ:LTRX) - Defense World

Sep 25, 2024

Sep 25, 2024

Victory Capital Management Inc. Acquires 13,972 Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Defense World

Sep 25, 2024

Sep 24, 2024

Great Point Partners LLC Purchases New Position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Defense World

Sep 24, 2024

Sep 24, 2024

Understanding LXRX’s book value per share for better investment insights - US Post News

Sep 24, 2024

Sep 24, 2024

Upward Trajectory: Lexicon Pharmaceuticals Inc (LXRX) Posts a Slidee, Closing at 1.58 - The Dwinnex

Sep 24, 2024

Sep 24, 2024

Light & Wonder price target lowered to $90 from $92 at Susquehanna - TipRanks

Sep 24, 2024

Sep 24, 2024

Bearish block trade of LIFETECH SCI(01302) 1.3M shares at $1.5, $1.95M turnover - AASTOCKS.com

Sep 24, 2024

Sep 20, 2024

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs - MSN

Sep 20, 2024

Sep 19, 2024

Why Is Lattice Semiconductor (LSCC) Stock Rocketing Higher Today By Stock Story - Investing.com Canada

Sep 19, 2024

Sep 17, 2024

Financial Analysis: Lexaria Bioscience (NASDAQ:LEXX) & Xeris Biopharma (NASDAQ:XERS) - Defense World

Sep 17, 2024

Sep 16, 2024

Lexaria (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program - Barchart

Sep 16, 2024

Sep 11, 2024

Best-selling drugs in pill form: How Lexaria plans to make it big on weight-loss wave - Kursiv Media

Sep 11, 2024